News

A study suggests that using a virus to purposely mutate genes that produce cancer-driving proteins could shed light on the resistance that develops to cancer drugs that target them.

According to a systematic review, regular muscle strengthening exercises associated with aerobic activities can reduce cancer mortality.

Researchers have discovered that patients with microsatellite stable colorectal cancer are more responsive to an innovative treatment that helps the immune system recognize and attack cancerous cells.

The risk that both tobacco and electronic cigarettes can pose to regular smokers’ health has been well documented, but a new UCLA study illustrates just how quickly vaping can affect the cells of even healthy younger non-smokers.

In researching childhood acute myeloid leukemia, scientists have found that in comparison to children with an above-average number of DNA changes, those with the same amount of DNA changes as healthy blood stem cells have a poorer chance of survival.

Pancreatic cancer is one of the deadliest forms of cancer, with fewer than 10% of patients surviving for five years after diagnosis. Pancreatic tumors often become resistant to chemotherapies. Researchers have now developed an immunotherapy strategy and shown that it can eliminate pancreatic tumors in mice.

A team of researchers has developed the largest and most comprehensive molecular map to date of lung squamous cell carcinoma. The database, which brings proteomic, transcriptomic and genomic data together, can be used to find potential new drug targets and identify underlying disease mechanisms related to therapy resistance.

Researchers have used artificial intelligence to develop a way to accurately predict which skin cancers are highly metastatic. The findings show the potential for AI-based tools to revolutionize pathology for cancer and a variety of other diseases.

Single strands of collagen assemble to form stable fibers that give structure to connective tissue such as skin, tendons, cartilage and bones. Researchers have now developed a multi-component molecule that interacts with collagen and can be used to illuminate new tissue growth in the body.

A new study reveals that an RNA-modifying protein known as METTL1 in tumor cells could be targeted to treat some aggressive cancers including brain, blood, skin, and kidney.